🔎 Trials Near Me

Home › Urogenital Cancer › Florida

Pag-aaral pangklinika para sa Urogenital Cancer sa Florida

6 pag-aaral para sa Urogenital Cancer ang naghahanap ng mga kalahok sa mga site sa Florida.

Mga Lungsod sa Florida

Opisyal na teksto ng pag-aaral (English)

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • Holy Cross Hospital, Fort Lauderdale
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT03866382

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

  • University of Florida, Gainesville
  • Mount Sinai Medical Center of Florida, Inc., Miami
  • H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., Tampa
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT05874921

Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

  • Florida Cancer Specialists, Sarasota
Nagre-recruitPhase 1/2
Edad 18 pataas · Kalalakihan · Na-update Set 25, 2026 · NCT06800313

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

  • AdventHealth Celebration, Celebration
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT05592626

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

  • Sylvester Comprehensive Cancer Center, Miami
  • Hematology Oncology Associates of the Treasure Coast, Port Saint Lucie
Nagre-recruitPhase 1
Edad 18 pataas · Kalalakihan · Na-update Hul 9, 2026 · NCT07103018

Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection

  • Biogenix Molecular LLC, Miami
  • NovaCure Health, Miami
Nagre-recruitPhase 1/2
Edad 18 pataas · Kalalakihan · Na-update May 14, 2026 · NCT05413850

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.